Starting early to control all risk factors in order to prevent coronary heart disease

Clinical Lipidology

Volumn 5, Issue 1, 2010, Pages 87-93

  McGill Jr , Henry C ^a   McMahan, C Alex ^b  

^a SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Atherosclerosis; Coronary heart disease; Prevention; Risk factors; Youth

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CONTROL STRATEGY; DIETARY INTAKE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; GROUPS BY AGE; HUMAN; ISCHEMIC HEART DISEASE; LIFESTYLE MODIFICATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

EID: 77649093038     PISSN: 17460875     EISSN: None     Source Type: Journal    
DOI: 10.2217/clp.09.82     Document Type: Review

References (42)

1. Steinberg D: Thematic review series: the pathogenesis of atherosclerosis. An interpretive history of the cholesterol controversy, part V: the discovery of the statins and the end of the controversy. J. Lipid Res. 47, 1339-1351 (2006).
2. Hypertension Detection and Follow-Up Program Cooperative Group: Effect of stepped care treatment on the incidence of myocardial infarction and angina pectoris. Hypertension 6(2 Pt 2), 198-206 (1984).
3. Critchley JA, Capewell S: Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. JAMA 290, 86-97 (2003).
4. Alexander JK: Obesity and coronary heart disease. Am. J. Med. Sci. 321, 215-224 (2001).
5. Van Gaal LF, Mertens IL, De Block CE: Mechanisms linking obesity with cardiovascular disease. Nature 444, 875-880 (2006).
6. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA: 10-year follow-up of intensive glucose control in Type 2 diabetes. N. Engl. J. Med. 359, 1577-1589 (2008).
7. Nissen SE, Nicholls SJ, Sipahi I et al.: Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA 295, 1556-1565 (2006).
8. American Heart Association: Dietary fat and its relation to heart attacks and strokes. Circulation 23, 133-136 (1961).
9. National Cholesterol Education Program: Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. NIH Publication No. 88-2925, National Heart Lung and Blood Institute, ML, USA (1988).
10. Grundy SM, Balady GJ, Criqui MH et al.: Primary prevention of coronary heart disease: guidance from Framingham: a statement for healthcare professionals from the AHA Task Force on Risk Reduction. Circulation 97, 1876-1887 (1998).
11. Smith SC Jr, Blair SN, Bonow RO et al.: AHA/ACC scientific statement: AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation 104, 1577-1579 (2001).
12. National Cholesterol Education Program: Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106, 3143-3421 (2002).
13. McGill HC Jr, Geer JC, Strong JP: Natural history of human atherosclerotic lesions. In: Atherosclerosis and Its Origin. Sandler M, Bourne GH (Eds). New York Academic Press, NY, USA, 39-65 (1963).
14. Holman RL: Atherosclerosis - a pediatric nutrition problem? Am. J. Clin. Nutr. 9, 565-569 (1961).
15. Lauer RM, Connor WE, Leaverton PE, Reiter MA, Clarke WR: Coronary heart disease risk factors in school children: the Muscatine study. J. Pediatr. 86, 697-706 (1975).
16. Berenson GS, Foster TA, Frank GC et al.: Cardiovascular disease risk factor variables at the preschool age. The Bogalusa Heart Study. Circulation 57, 603-612 (1978).
17. Akerblom HK, Uhari M, Pesonen E et al.: Cardiovascular risk in young Finns. Ann. Med. 23, 35-39 (1991).
18. Committee on Nutrition of the American Academy of Pediatrics: Childhood diet and coronary heart disease. Pediatrics 49, 305-307 (1972).
19. Glueck CJ, McGill HC Jr, Shank RE, Lauer RM: Value and safety of diet modification to control hyperlipidemia in childhood and adolescence. A statement for physicians. Circulation 58, A381-A385 (1978).
20. Strong WB, Deckelbaum RJ, Gidding SS et al.: Integrated cardiovascular health promotion in childhood: a statement for health professionals from the Subcommittee on Atherosclerosis and Hypertension in Childhood of the Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 85, 1638-1650 (1992).
21. Kannel WB, Dawber TR: Atherosclerosis as a pediatric problem. J. Pediatr. 80, 544-554 (1972).
22. Berenson GS, Frank GC, Hunter SM et al.: Cardiovascular risk factors in children: should they concern the pediatrician? Am. J. Dis. Child. 136, 855-862 (1982).
23. Gidding SS: The rationale for lowering serum cholesterol levels in American children. Am. J. Dis. Child. 147, 386-392 (1993).
24. Van Horn L, Greenland P: Prevention of coronary artery disease is a pediatric problem. JAMA 278, 1779-1780 (1997).
25. Steinberg D, Glass CK, Witztum JL: Evidence mandating earlier and more aggressive treatment of hypercholesterolemia. Circulation 118, 672-677 (2008).
26. Committee on Prevention of Obesity in Children and Youth: Preventing Childhood Obesity: Health in the Balance. National Academies Press, DC, USA (2005).
27. McMahan CA, Gidding SS, Fayad ZA et al.: Risk scores predict atherosclerotic lesions in young people. Arch. Intern. Med. 165, 883-890 (2005).
28. McGill HC Jr, McMahan CA, Gidding SS: Preventing heart disease in the 21st Century: implications of the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) study. Circulation 117, 1216-1227 (2008).
29. Mahoney LT, Burns TL, Stanford W et al.: Coronary risk factors measured in childhood and young adult life are associated with coronary artery calcification in young adults: the Muscatine Study. J. Am. Coll. Cardiol. 27, 277-284 (1996).
30. Davis PH, Dawson JD, Riley WA, Lauer RM: Carotid intimal-medial thickness is related to cardiovascular risk factors measured from childhood through middle age: the Muscatine Study. Circulation 104, 2815-2819 (2001).
31. Li S, Chen W, Srinivasan SR et al.: Childhood cardiovascular risk factors and carotid vascular changes in adulthood: the Bogalusa Heart Study. JAMA 290, 2271-2276 (2003).
32. Raitakari O, Juonala M, Kahonen M et al.: Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood. The Cardiovascular Risk in Young Finns study. JAMA 290, 2277-2283 (2003).
33. Gidding SS, McMahan CA, McGill HC et al.: Prediction of coronary artery calcium in young adults using the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) risk score. Arch. Intern. Med. 166, 2341-2347 (2006).
34. McMahan CA, Gidding SS, Vikari JSA et al.: Association of Pathobiological Determinants of Atherosclerosis in Youth risk score and 15-year change in risk score with carotid artery intima-media thickness in young adults (from the Cardiovascular Risk in Young Finns study). Am. J. Cardiol. 100, 1124-1129 (2007).
35. Keys A: Coronary Heart Disease in Seven Countries. American Heart Association Inc., NY, USA (1970).
36. Jacobs DR Jr, Adachi H, Mulder I et al.: Cigarette smoking and mortality risk: twenty-five-year follow-up of the Seven Countries Study. Arch. Intern. Med. 159, 733-740 (1999).
37. Jee SH, Suh I, Kim IS, Appel LJ: Smoking and atherosclerotic cardiovascular disease in men with low levels of serum cholesterol: the Korea Medical Insurance Corporation study. JAMA 282, 2149-2155 (1999).
38. Stamler J, Wentworth D, Neaton JD; for the MRFIT Research Group: Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356 222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA 256, 2823-2828 (1986).
39. Cohen JC, Boerwinkle E, Mosley TH Jr, Hobbs HH: Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N. Engl. J. Med. 354, 1264-1272 (2006).
40. Brown MS, Goldstein JL: Biomedicine. Lowering LDL - not only how low, but how long? Science 311, 1721-1723 (2006).
41. McGill HC Jr, McMahan CA, Zieske AW et al.; for the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group: Effects of nonlipid risk factors on atherosclerosis in youth with a favorable lipoprotein profile. Circulation 103, 1546-1550 (2001).
42. National Cholesterol Education Program (US): Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. NIH Publication No. 93-3095, NHLBI, Health and Human Services Dept, MD, USA (1993).